# A Trial of Sertraline in Young Children With Autism Spectrum Disorder

> **NCT02385799** · PHASE2 · COMPLETED · sponsor: **Randi J. Hagerman, MD** · enrollment: 58 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Sertraline Liquid Placebo
- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT02385799
- **Lead sponsor:** Randi J. Hagerman, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385799, "A Trial of Sertraline in Young Children With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02385799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*